Label Promotion of Drugs and Medical Devices 2018

Overview:
This session sets the context for the off-label promotion of medical
products starting with early history and moving to the most recent
history of FDA's decision on guidance documents.

Why should you Attend:
This session will discuss comments from industry, health care
providers, health care insurers and other concerned parties. The
latest legal considerations, decisions and conclusions will be
discussed as well as future expectations for off-label promotion of
medical products.

Who Will Benefit:

• Quality Managers
• Quality Engineers
• Regulatory Affairs
• Regulatory Attorneys
• Doctors
• Health Insurance

Speaker Profile:
Angela Bazigos is the CEO of Touchstone Technologies Inc. She has
degrees in Microbiology and Computing and 40 years of experience
in the Life Sciences, Healthcare & Public Health Services. Experience
combines Quality Assurance, Regulatory Compliance, Business
Administration, Information Technology, Project Management,
Clinical Lab Science, Microbiology, Food Safety & Turnarounds. Past
employers / clients include Royal Berkshire Hospital, Roche,
Novartis, Genentech, PriceWaterhouseCoopers & Stanford Hospital.

Event Fee: One Dial-in One Attendee Price: US$290.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: [email protected]